Caribou Biosciences Inc (CRBU)

NASDAQ
10.27
-0.37(-3.48%)
  • Volume:
    421,343
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    10.16 - 11.03

CRBU Overview

Prev. Close
10.64
Day's Range
10.16-11.03
Revenue
19.41M
Open
10.83
52 wk Range
9.34-32.65
EPS
-
Volume
421,343
Market Cap
618.17M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
422,490
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
60,192,061
Next Earnings Date
Mar 02, 2022
What is your sentiment on Caribou Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

Caribou Biosciences Inc Company Profile

Employees
67

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. Caribou Biosciences has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • end of next week 56USD
    0
    • too the moon
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.